Max Bautin - Profile and Investment Details

Investor Profile

Max Bautin is a Venture Capital, Private Equity Firm based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Closed Loop Medicine, Nu Quantum, SPECTRAL EDGE (Meta), Porotech, Funderbeam, Thought Machine, Trogenix, Spectral Edge, IONATE, Nyobolt, Neul, Myrtle Software, TurinTech, Apperio, MQube, Opteran, Neul Ltd - acquired by Huawei, Oxford Space Systems, Iotic, Sirigen, Privitar, AccelerComm, Pangaea Data, Stillfront Group, Rosslyn Data Technologies PLC, Cambridge GaN Devices, Grapeshot, Phonetic Arts - acquired by GoogleMolyon, Spikes Cavell & Co, Phonetic Arts, Divido, miiCard, Digital Assess, Invest Europe, CyberSmart, Cambridge Communication Systems, AccelerComm Ltd, Wluper, The ID Co., CybSafe, Grapeshot (Acquired by Oracle), Speechmatics, Concirrus, Senseye, Sirigen Group Ltd - acquired by Becton Dickinson, Unbound, Focal Point Positioning, causaLens, Audio Analytic, Bloomsbury AI, Synthesized, FNA, QuadSAT, BioBeats, KisanHub, Paragraf, Focal Point Data Risk, Dataswift, Virti, Desktop Genetics, BMLL Technologies, Power Challenge - acquired by Stillfront, Imandra, Fluidic Analytics, Optellum, Neurovalens, M∙QUBE, Stillfront Group AB, ChargePoint Services, TOffeeAM, . Over time, Max Bautin has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Max Bautin is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Clean Tech, Health Care, Emerging Technology, Talent Management, Research and Development, Telecommunications, Cybersecurity, DeepTech, Disruptive Innovation, Wellness, Enterprise Software, Investment Management, Digital Media, Energy, Software Solutions, Strategic Partnerships, Life Science, Banking, Artificial Intelligence (AI), Robotics, Startups, Information Technology (IT), Analytics, Cloud Computing, Internet of Things (IoT), Venture Fundraising, Technology, Synthetic Biology, Finance, IoT, Automation, Software, Intellectual Property, Manufacturing, Biotechnology, Medical Devices, Entrepreneurship, Precision Medicine, Energy Tech, Innovation, Clinical Trials, Groceries, FinTech, Disruptive technology, Digital Transformation, Space Technology, Research, Data Privacy, Agriculture, Consulting, Sustainable Energy, Hardware, UK Startups, Utilities, Mergers and Acquisitions, Generative Tech/AI, Digital Health, Renewable Energy, Medical, SaaS, Battery, Information Technology, B2B, Advanced Materials, Health Tech, Machine Learning, Quantum Computing, Material Science, Pharmaceuticals, Healthcare Technology, Risk Management, Acquisitions may find it worthwhile to explore potential connections with Max Bautin, as their portfolio suggests a familiarity and interest in this area.

Understanding Max Bautin’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.